EMR
May 7, 2025 - AI Summary
Overvalued by 56.2% based on the discounted cash flow analysis.
Market cap | $63.31 Billion |
---|---|
Enterprise Value | $68.10 Billion |
Dividend Yield | $2.105 (1.87027987561084%) |
Earnings per Share | $3.44 |
Beta | 1.25 |
Outstanding Shares | 568,500,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 26.54 |
---|---|
PEG | 8.51 |
Price to Sales | 4.05 |
Price to Book Ratio | 2.64 |
Enterprise Value to Revenue | 3.88 |
Enterprise Value to EBIT | -138.41 |
Enterprise Value to Net Income | 28 |
Total Debt to Enterprise | 0.11 |
Debt to Equity | 0.29 |
No data
No data